LEADER 03639nam  22006855  450 
001 9910620200803321
005 20251009103136.0
010   $a3-031-10090-5
024 7 $a10.1007/978-3-031-10090-1
035   $a(MiAaPQ)EBC7120753
035   $a(Au-PeEL)EBL7120753
035   $a(CKB)25188966800041
035   $a(PPN)265862108
035   $a(DE-He213)978-3-031-10090-1
035   $a(OCoLC)1348949104
035   $a(EXLCZ)9925188966800041
100   $a20221022d2022      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aArtificial Intelligence in PET/CT Oncologic Imaging /$fedited by John A. Andreou, Paris A. Kosmidis, Athanasios D. Gouliamos
205   $a1st ed. 2022.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2022.
215   $a1 online resource (156 pages)
225 1 $aMedicine Series
311 08$aPrint version: Andreou, John A. Artificial Intelligence in PET/CT Oncologic Imaging Cham : Springer International Publishing AG,c2022 9783031100895 
320   $aIncludes bibliographical references and index.
327   $a1. Introduction : Artificial intelligence (AI) systems for Oncology -- 2. PET in Bone and Soft tissue tumors -- 3. (CNS) PET/CT: current AI applications -- 4. PET/CT findings in Head and Neck Cancer, current AI applications -- 5. PET/CT in Lung cancer, current AI applications -- 6. Breast cancer: PET/CT imaging, AI applications -- 7. PET/CT in Gynecologic cancer, current AI applications -- 8. PET/CT in Rectal cancer, current AI applications -- 9. PET/CT in Neuroendocrine tumors, current AI applications -- 10. PET/CT in the evaluation of Adrenal gland mass -- 11. PET/CT in Renal cancer -- 12. PET/CT in Testicular cancer -- 13. PET/CT in Prostate cancer -- 14. PET/CT in Malignant Lymphomas.
330   $aThis book presents artificial intelligence applications that may help in detecting disease, defining tissue characterization (benign vs malignant), staging and correlation with molecular biomarkers. Originally positioned as a means for noninvasive molecular phenotyping and quantification in the 1970s, PET's technological improvements in the 2000s generated renewed interest in quantification, which has grown over the last five years. This progress is parallel with the development of Artificial intelligence (AI) systems for Oncology which aim at providing the best possible treatment to patients suffering from lung, breast, brain, prostate, liver and other types of cancer. The chapters provide an overview of the use of AI in PET/CT imaging for various types of cancer, and it will be an invaluable tool especially for nuclear medicine physicians and oncologists.
410  0$aMedicine Series
606   $aRadiology
606   $aNuclear medicine
606   $aOncology
606   $aComputer science
606   $aRadiology
606   $aNuclear Medicine
606   $aOncology
606   $aComputer Science
615  0$aRadiology.
615  0$aNuclear medicine.
615  0$aOncology.
615  0$aComputer science.
615 14$aRadiology.
615 24$aNuclear Medicine.
615 24$aOncology.
615 24$aComputer Science.
676   $a610.285
676   $a616.99407575
702   $aKosmidis$b Paris A.
702   $aGouliamos$b Athanasios D.
702   $aAndreou$b John A.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910620200803321
996   $aArtificial Intelligence in PET$92960345
997   $aUNINA